Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery
NCT ID: NCT01509950
Last Updated: 2019-03-04
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2012-01-31
2013-05-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study Comparing Two Different Techniques for Closing the Skin After a Cesarean Delivery
NCT00293683
Staples Versus Suture for Cesarean Wound Closure
NCT01008449
Sutures vs. Staples Skin Closure After C-section in Obese Patients
NCT01820221
A Clinical Trial of Subcuticular Staples Versus Subcuticular Suture for Cesarean Section Skin Closure
NCT01753518
5-0 Prolene Versus 5-0 Fast Absorbing Gut
NCT03303014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
When a participating patient is scheduled for a cesarean section, she will be randomized to Arm 1 (Staples) or Arm 2 (Prolene) or Arm 3 (Monocryl or Vicryl absorbable suture). She will be treated as per standard of care and her cesarean section performed per physician discretion. After the closure of the fascial layer, the surgeons will follow the same protocol for each study participant, including wound irrigation with warm sterile saline and reapproximation of the subcutaneous layer if greater than 2.0 cm in depth (per standard of care). The patient in Arm 1 will have skin closure with staples. The patient in Arm 2 will have skin closure with 2-0 Prolene in a subcuticular fashion. The patient in Arm 3 will have skin closure with monocryl or vicryl in the standard fashion. Patients in Arms 1 and 2 will have their closure material removed at the physician's discretion per the standard of care at post-operative day 3 or 4.
Pain level will be assessed on the first and third or fourth day after surgery and again at six weeks.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Staples
Use of staples for skin closure at cesarean section
Staples
Staples for closure of cesarean section skin incision
Prolene non-absorbable sutures
Use of Prolene non-absorbable sutures for skin closure at cesarean section
Prolene non-absorbable sutures
Prolene non-absorbable sutures for closure of cesarean skin incision
Absorbable sutures
Use of absorbable sutures for skin closure at cesarean section; monocryl or vicryl.
Absorbable Sutures
Absorbable sutures for closure of cesarean skin incision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Staples
Staples for closure of cesarean section skin incision
Prolene non-absorbable sutures
Prolene non-absorbable sutures for closure of cesarean skin incision
Absorbable Sutures
Absorbable sutures for closure of cesarean skin incision
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Maternal age greater than or equal to 18 years of age
* Gestational age greater than or equal to 34 weeks
* Elective and non-elective cesarean section
Exclusion Criteria
* BMI greater than 35
* Pre-operative diagnosis of chorioamnionitis
* History of drug or alcohol abuse
* Contraindication to NSAIDs
* Chronic pain diagnosis
* Narcotic use prior to pregnancy
* Maternal age less than 18 years of age
* General anesthesia
* Chorioamnionitis, clinical suspicion of chorioamnionitis, or risk factors for chorioamnionitis (membrane rupture greater than 18 hours, GBS positive status)
* Vertical skin incision
18 Years
55 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Stanford University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Natali Aziz
Clinical Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Natali Aziz, MD
Role: PRINCIPAL_INVESTIGATOR
Stanford University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Lucile Packard Childrens Hospital
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22389
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.